Regulacje i polityka gospodarcza · 17/11/2000

DEA Classifies Dihydroetorphine as Schedule II Controlled Substance Under the Controlled Substances Act

The US Drug Enforcement Administration (DEA) has finalized a rule classifying dihydroetorphine, a derivative of thebaine, as a Schedule II controlled substance under the Controlled Substances Act (CSA) due to its international control under the Single Convention on Narcotic Drugs, 1961, and its relation to opium and opiates.